The session will provide participants with insight into insomnia management through discussions of assessment, treatment implications, and patient education strategies.

7:00-7:30 a.m. Breakfast
7:30-9:00 a.m. Symposium

This activity is supported by an educational grant from sanofi-aventis U.S.
This activity is sponsored by CME LLC. MediCom Worldwide, Inc. is the content provider.

Although close to 70% of all individuals with dementia suffer from Alzheimer's disease, there are still many other critically important subtypes of dementia that must be recognized by the clinician. This symposium will provide a broad definition of dementia and then focus on some of the most important medically-induced subtypes and how to recognize them. Subtypes to be covered include normal pressure hydrocephalus, dementias due to human prion diseases and HIV infection, traumatic brain injury, and dementias that result from toxic exposures such as to alcohol or heavy metals.

After Participating in this activity participants will be able to:

1. Discuss the entire spectrum of non-Alzheimer dementia subtypes
2. List what diagnostic signs point to a potential medically-induced form of dementia.
3. Discuss diagnosis and treatment of the following dementia subtypes: A) Normal pressure hydrocephalus.
4. Human prion diseases.
5. HIV associated dementia.
6. Dementia due to traumatic brain injury(e.g., dementia pugilistica).
7. Dementia due to ETOH and other toxic exposures. F) Dementia due to neurodegenerative diseases (e.g., multiple sclerosis).

Dreams have been an important aspect of man's search for meaning for over 4000 years. In this seminar, attendees will be exposed to a modern approach to dream analysis, one that integrates the insights and approaches of such luminaries as Freud, Jung, Perls and Hall. Research will be provided to validate the usefulness of using dreams in therapy and the applicability of the "continuity model". Sleep studies will also be used to better understand the stages of sleep and patterns of REM and NREM sleep. Case studies will be presented as well to illustrate a modern approach to helping clients remember and find meaning in their dreams.

Upon the completion of this activity, participants will be able to:

1. Identify benefits of dream work;
2. Review historical models;
3. Present a modern model;
4. Debunk common myths about dreams; and
5. Review relevant research.CA112

Many experts say that the key to treating patients with agitation, aggression and dangerousness is to understand the factors that lead to this behavior and the treatments that are currently available.

By participating in this activity, attendees will be able to:

1. Discuss the etiology of agitative and aggressive feeling and dangerous behavior, and explore how various forms of psychiatric comorbidity increase the likelihood of such behavior;
2. Recognize the effective ways to conduct accurate risk assessments; and
3. Identify various integrated treatments, including cognitive behavioral and other skill-based interventions, to address such behavior.

Upon the completion of this activity, participants will be able to:

1. Avoid major pitfalls of both tangible & intangible marketing;
2. . Explain the ramifications of patient services and integrate this knowledge into better patient care; and
3. Develop a marketing budget and an effective 12-Month Marketing Plan, individualized for their practice.

Increasing numbers of teens and young adults cut, scratch or burn themselves to feel better. Treatment providers (and family members) can inadvertently escalate self-injury unless shown effective ways to support these individuals. Join us in this high-energy, practical session replete with video clips and case examples.

By participating in this activity, attendees will be able to:

1. Explain why individuals self-injure and how "cutting" and "burning" differ from suicide;
2. Learn to screen for self-injury; and
3. Learn practical and effective "strategies" to use with individuals who engage in this harmful behavior.

Psychiatric masquerades are medical and/or neurological conditions which present primarily with psychiatric or behavioral symptoms. The conditions included in this category range from neurological disorders (e.g. seizure disorders and MS), to infectious diseases (e.g. syphilis, herpes and HIV), to connective tissue disorders (e.g. vasculitis and SLE), to malignancies (e.g., paraneoplastic syndromes and pancreatic cancer), to metabolic disorders (e.g. Wilson's disease and prophyria), to various toxins and substances our patients may be exposed to. In this lecture, we will discuss the presentation and symptoms of the most common masquerades, focusing on pearls for timely diagnosis, and discuss potential management and treatment strategies.

By participating in this activity, attendees will be able to:

1. Recognize the most common infectious disorders presenting with psychiatric symptoms;
2. Explain the incidence, epidemiology and clinical features of the most common neuropsychiatric disorders masquerading as psychiatric illness;
3. Recommend the research-based, effective treatment options for these conditions.

Treating patients who suffer from Anorexia and/or Bulimia can cause psychiatrists and psychotherapists tremendous frustration or great satisfaction. Successful treatment of Eating Disorders requires a complete understanding of the multiple etiologies involved, the psychotherapies required and the sophisticated use of psychotropic medications. We will focus in this session on the keys optimizing clinical outcomes and achieving remission based upon the biopsychosocial etiology of these disorders. We will identify the factors that result in failure and frustration, as well as the keys to successfully reach appropriate treatment goals.

By participating in this activity, learners will be able to:

1. Understand the multimodal treatment necessary for the successful treatment of these biopsychosocial disorders.
2. Enhance their ability to successfully utilize cognitive/behavioral psychotherapeutic techniques within a dynamic understanding of Anorexia and Bulimia.
3. Update their ability to successfully utilize psychopharmacologic agents to treat Eating Disorders.

Forensic psychiatry is an emerging area of specialization in psychiatry and it is important for general psychiatrists to familiarize with this area to help in their interface with the legal system.

By participating in this activity, attendees will be able to:

1. Discuss the commonly encountered psychiatric problems in correctional centers;
2. To become familiar with the prevalence of mental illness in Correctional facilities and to understand the complexities of assessment and treatment of the mentally ill in this setting; and
3. Identify the legal challenges practitioners face.

The psychiatric consultant is often asked to help manage the MOST CHALLENGING demented patients. Often , these patients have Lewy Body Dementia or FrontoTemporal Dementia. Learn how to recognize and treat these conditions with actual patient videos which demonstrate key findings.

Upon the completion of this activity, participants will be able to:

1. Discuss the diagnosis and clinical presentation of Lewy Body Dementia and Frontotemporal Dementia;
2. Describe the pathophysiological mechanisms associated with dementia;
3. Review the nonpharmacological and pharmacological treatments for various dementia

Spirituality and religion are important aspects of life. While research indicates that clients want providers to ask about these areas of their lives, however, mental health providers are often ill-prepared to do so. This course will expose participants to several different mnemonic tools which are useful in interviewing clients about religion and spirituality. Special focus will be on the ChaMB mnemonic, an interviewing tool developed by the presenter for use with patients facing existential crises in their lives (i.e. death of a loved one; terminal illness; chronic illness etc.). Case examples will demonstrate the utility of this tool in both in-patient and out-patient settings.

Upon the completion of this activity, participants will be able to:

1. Provide mnemonic to help clinicians interview patients having experienced traumatic events;
2. Contrast with other tools to conduct spiritual interview; and
3. Use case material to illustrate efficacy.
4. Review relevant research findings

Do the media merely "reflect" the real world - as Hollywood and network executives would have us believe - or do they cause real-life problems as well? Teenagers spend an average of 6 hours a day with media: how much of an impact does that have on their attitudes and behavior? The answer lies partially in some voluminous and difficult media research and partially in the realm of common sense. This talk will try to illuminate what we know about the impact of the media on adolescents, what we don't know, and what we need to do to find out. The topics of violence, advertising, obesity, sex & sexuality, drugs, and new technologies will be explored, along with videotaped clips to illustrate the problems and some of the solutions. Several suggestions for parents and for schools will be presented.

Upon the completion of this activity, participants will be able to:

1. Illustrate the nature of current television programming for children and teenagers (topic areas = violence, commercialism, sex, drugs).
2. Discuss the impact of television programming on children and teenagers and how such effects were determined by research.
3. Analyze how the adverse effects of TV and other media can be mediated by parents and by school media literacy program.

Behavioral Health is constantly changing, and a large percentage of behavioral health organizations have seen a steady increase in denied claim and reduced revenue. These health care claims which are rejected or denied lead to millions of dollars of lost revenue each year for health care organizations. Begin turning around the reduced revenue of your organization by attending Understanding Managed Care: Increasing Profitability. This presentation is a must attend event for anyone working in the health care field. Impactful change is possible, and there are proven key steps to improving revenue. Find out more about this topic and what you can do to optimize profitability, decrease costly denials, gain a full working knowledge of coding, and learn what strategies pay when it comes to collections.

Upon the completion of this activity, participants will:

1. Have an understanding of the importance of data, tracking, and benchmarking and be able to begin to use these principles to improve outcomes in their practice.
2. Be able to utilize at least three strategies to immediately improve their practice's bottom line.
3. Understand the importance of the billing cycle and ways to improve the amount and rate at which revenue is collected.

Increasing numbers of teens and young adults cut, scratch or burn themselves to feel better. Treatment providers (and family members) can inadvertently escalate self-injury unless shown effective ways to support these individuals. Join us in this high-energy, practical session replete with video clips and case examples.

By participating in this activity, attendees will be able to:

1. Explain why individuals self-injure and how "cutting" and "burning" differ from suicide;
2. Learn to screen for self-injury; and
3. Learn practical and effective "strategies" to use with individuals who engage in this harmful behavior.

Psychiatric masquerades are medical and/or neurological conditions which present primarily with psychiatric or behavioral symptoms. The conditions included in this category range from neurological disorders (e.g. seizure disorders and MS), to infectious diseases (e.g. syphilis, herpes and HIV), to connective tissue disorders (e.g. vasculitis and SLE), to malignancies (e.g., paraneoplastic syndromes and pancreatic cancer), to metabolic disorders (e.g. Wilson's disease and prophyria), to various toxins and substances our patients may be exposed to. In this lecture, we will discuss the presentation and symptoms of the most common masquerades, focusing on pearls for timely diagnosis, and discuss potential management and treatment strategies.

By participating in this activity, attendees will be able to:

1. Recognize the most common infectious disorders presenting with psychiatric symptoms;
2. Explain the incidence, epidemiology and clinical features of the most common neuropsychiatric disorders masquerading as psychiatric illness;
3. Recommend the research-based, effective treatment options for these conditions.

While we attempt to make evidence-based decisions, the evidence in Psychiatry is incomplete and contradictory. Psychiatry is usually practiced behind closed doors in 1 to 1 confidential patient interactions. We want to learn how our psychiatric colleagues make difficult psychiatric decisions and treatment recommendations, but we have few opportunities to do so. Do they prescribe antidepressants for bipolar depression? or give benzodiazepines to patients with histories of substance abuse? How do they choose between augmentation options? Etc. When, Why and How do they make these and other complex treatment decisions? Join us in this stimulating interactive session as we utilize computerized response systems to explore these treatment questions and dilemmas. Learn, engage and participate with us. Bring your own cases, questions and treatment dilemmas.

By participating in this session, learners will be able to:

1. Learn how fellow psychiatric colleagues approach challenging treatment decisions in Mood and Anxiety Disorders.
2. Recognize the need for treatment decisions to be based on scientific evidence and clinical experience and acumen.
3. Enhance your ability to successfully treat Mood and Anxiety Disorders.

Health care reform has opened the door to integrating psychiatric mental health and behavioral interventions into medical settings. With a call for the Integrated Medical Home, prevention and patient wellness education will be rewarded as an innovation that will drive down medical costs. This opens the door for psychiatric mental health practitioners of all levels to apply the evidence based practices of the field to short term treatments in primary care settings. To capitalize on this evolution of our professions, we need to understand how to work collaboratively with medical offices, and the new NCQA standards for the patient centered medical home that focuses on early identification, patient education and modalities that can be effective in treatment of psychiatric mental health and behavioral issues in the primary care environment. By understanding the business issues involved with using commercial-based insurance, psychiatric nurses (RN,CNS, or NP), and other psychiatric mental health clinicians will have new opportunities to engage his or her full scope of practice that will directly impact patients' lives.

Participants should be able to:

1. Identify elements of collaboration in medical setting;
2. Understand what is needed to get credentialed and paid for collaborative services;
3. Define the role and training needs to participate in collaborative care;
4. Illuminate the issues involved in creating a model of collaborative care programs in your community; and
5. Understand the steps needed in developing community outreach and collaboration tools.

The fastest growing age group in the country is individuals of 85 years and above. As a result, it is becoming increasingly common for therapists to work with a significant number of older clients. This symposium will provide a context for such work along with many therapeutic tools. The aging process will be described with a focus on changes in cognition and personality that are relevant to late-life psychopathology. The symposium will then jump right into the therapeutic setting, discussing the role of the therapist, the impact of countertransference and stigma, and an approach to the diagnostic interview and psychotherapy that is both practical and age-specific.

Upon the completion of this activity participants will be able to:

1. Review the aging process and its relevance to cognition and personality throughout the life cycle.
2. Describe age-specific challenges encountered in therapy.
3. Discuss the role of countertransference and stigma when working with older client.
4. Apply Learn practical psychotherapeutic modalities in later life patients.

The session will provide participants with practical tools for the continuity of care for patients with schizophrenia.

This activity is supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. administered by Ortho-McNeil Janssen Scientific Affairs, LLC

This activity is jointly sponsored by the Indiana University School of Medicine and CME LLC. CME Outfitters is the content provider.

The session will provide participants strategies and reinforcement in dose titration, multimodal treatment, and long-term treatment adherence for patients with ADHD.

12:15 - 12:45 p.m. Lunch
12:45- 2:15 p.m. Symposium

This activity is supported by an educational grant from McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC

This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC. Veritas Institute for Medical Education Inc. is the content provider.

The session will provide participants with strategies for improving the management of comorbid depression as well as chronic pain and other physical symptoms.

12:15PM-12:45 p.m. Lunch
12:45-2:15 p.m. Symposium

This activity is supported by an educational grant from Eli Lilly and Company.

This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC. The Institute for Continuing Healthcare Education is the content provider.

Get up to date review of our current understanding of the biological basis of Depression. Information will emphasize factors involved with aging, brain localization, neurotransmitters, hormones, and treatments for the elderly depressed patient.

1. Discuss the clinical and psychosocial impact of depression and the significance of sustained remission in optimizing patient outcomes;
2. Describe evidence for the neuroanatomical correlates of depression and their relationship to vascular diseases; and
3. Utilize a neurobiological understanding of depression in identifying the most appropriate treatment options for depressed patients.

For the first time in a decade, youth suicide is on the rise.

By participating in this activity, attendees will be able to:

1. Identify two new trends in youth suicide and why they are so troublesome;
2. List both the subtle and obvious factors leading to suicide in children and teens-including the "Big 3"; and
3. Describe the four essential parts of suicide screening of youth.

Walking away from the closed door of our office, into medical offices, opens the door for new applications of psychiatric mental health and behavioral interventions that will drive down medical costs. Collaborating with primary care providers directly in medical offices requires new skills built on the understanding of the office, community and patient cultures. This discussion about the integrated mental health will focus on clinical issues, skill development, complementary and alternative mental health practices and how to work with health care reform to perpetuate a new clinical environment rich in opportunities for clinical research and outcome studies. This presentation will address behavioral interventions indicated for several medical conditions (diabetes, cardiac disease, infertility, pulmonary disease, and autoimmune diseases) as well as the collaborative process. While this presentation will highlight the role of psychiatric nurse in this exciting milieu, it could enhance the knowledge base of all practitioners interested in participating in a integrated medical home.

Participants should be able to:

1. Identify boundaries to the collaborative process and appropriate safeguards for patient information;
2. Define the process for comprehensive assessment and wellness planning;
3. Define the impact of mental illness on specific diseases discussed;
4. Identify collaborative involvement, role in referral and follow up;
5. Develop a tool specific to attendees' practices that will enhance the role, health care management, and communication between team members.

The evidence base for pharmacotherapy of PTSD has grown by leaps and bounds in the past 10 years. Early studies of amitriptyline and phenelzine showed some promise for treatment of PTSD. But sample sizes were small and larger-scale studies have not been conducted. Only one class of drugs, the selective serotonin reuptake inhibitor (SSRIs) has members of the class FDA-approved for PTSD. Numerous large, multi-center trials of SSRIs (and, more recently, several large trials with dual norepinephrine serotonin reuptake inhibitors [NSRIs]) conclusively demonstrate their short- and intermediate-term efficacy, but response rates are modest and the optimal duration of treatment is unclear. Furthermore, the efficacy of SSRIs in some populations (e.g., combat veterans with PTSD) has been questioned. As awareness of the prevalence and seriousness of PTSD has increased, so has the impetus to develop new and better treatments. Several other classes of medications, including anticonvulsants, atypical antipsychotics, and adrenergic agents (e.g., prazosin) have shown promise in relatively small studies for either monotherapy or adjunctive use. For some medications, large randomized controlled trials (RCTs) have been negative (e.g., the anticonvulsant tiagabine), whereas for others such trials are either ongoing (e.g., prazosin and risperidone) or have yet to be conducted (e.g., lamotrigine). A role for combined psychotherapy and pharmacotherapy of PTSD will be discussed.

Upon the completion of this activity, particpants will be able to:

1. List FDA approved treatments for posttraumatic stress disorder (PTSD).
2. Identify the different classes of psychotropic agents that may be useful in the treatment of PTSD.
3. Discuss the limitations of the available evidence base for PTSD pharmacotherapy and of the need for more studies and better therapeutics.

This introductory lecture will review the history of Hypnosis and its use in medical and psychiatric conditions. Common misconceptions about Hypnosis will be discussed as well as an introduction to hypnotic phenomena. Lastly, vignettes will be presented demonstrating the application of Hypnosis in several clinical conditions.

Upon the Completion of this activity, participants will be able to:

1. Discuss the common misconceptions about Hypnosis with patients and clients and to present the use of Hypnosis in such a way that will set the stage for a more successful outcome with this modality.
2. Use an understanding of the hypnotic phenomena and suggestibility tests to decide if Hypnosis may be a useful intervention for a given patient or client.
3. List the clinical uses of Hypnosis and to be able to apply this therapy to a wide range of medical, psychiatric, and psychotherapeutic settings.

Upon the completion of this activity, participants will be able to:

1. Recognize patients with environmental sensitivities by asking a few screening questions.
2. Help the patient determine what environmental factors are or have potentially affected their health. Focusing on mold at home or work as a common culprit.
3. Recognize adrenal insufficiency, dysautonomia, mitochondrial compromise and chemical sensitivity in your patients and obtaining proper referral for these conditions in your area.

Upon the completion of this activity participants will be able to:

1. Apply evidence-based medicine to the treatment of TIA and Stroke;
2. Learn different stroke subtypes, risk factors, and clinical syndromes;
3. Discuss new definition of TIA; and
4. Understand the role of intravenous vs. intra-arterial thrombolysis in acute stroke.

Both psychiatric and nonpsychiatric clinicians tend to underutilize screeners and rating instruments in their busy practices. This is an error worth rectifying expeditiously for the following reasons: use of screeners and rating instruments can actually improve outcomes, it can be very time efficient and many quality tools are available for no charge. This workshop will show videos of a few clinical scenarios and discuss what tools might have been appropriate to use. Copies of noncopyrighted screeners and rating instruments, appropriate for both psychiatric and nonpsychiatric settings, will be made available to participants. A toolkit filled of screeners and rating instruments will be brought to the workshop to show participants how they can create one for their own use.

By participating in this activity, attendees will be able to:

1. Recognize the many noncopyrighted tools available for clinician use covering a range of psychiatric disorders;
2. Define these tools that are very time efficient and improve diagnostic yield; and
3. Describe how to choose the right tool and how to score them.